Martin Tremblay

Martin Tremblay is an accomplished medicinal chemist with extensive experience in drug discovery and development. Currently serving as Vice President of Medicinal Chemistry at Abiologics since March 2025 and as a Drug Discovery Advisor at Neolys Pharma since July 2024, Martin previously held the position of Vice President at Parabilis Medicines from January 2018 to January 2024, where leadership of a chemistry team resulted in the advancement of innovative therapies. Prior roles include Executive Director of Chemistry at TESARO, Inc. and Senior Director of Small Molecule Discovery, overseeing significant collaborations in immuno-oncology. Martin's career began at Infinity Pharmaceuticals, where leadership of a multidisciplinary team led to the nomination of selective PI3K inhibitors as development candidates. Educationally, Martin completed postdoctoral studies in Chemistry at Scripps Research and earned a PhD from Université Laval.